What is LOPJLB’s current signal on BLTE?

LOPJLB’s latest quantitative signal on Belite Bio, Inc (BLTE) is SELL in a BEAR regime. Signals are updated daily.

What market regime is BLTE in?

Belite Bio, Inc (BLTE) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Belite Bio, Inc (BLTE) do?

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical tria…

Where is Belite Bio, Inc based / listed?

Belite Bio, Inc is based in US, listed on NASDAQ.

Belite Bio, Inc (BLTE)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$154.49+1.29%Close

SELLBEAR · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $6.2B
Beta: -1.23
P/E (TTM): -56.38

Short % float: 5.73%
Days to cover: 7.3
SI change: +0.7%

1W: -3.18%
1M: -11.76%

vs SPY 1W: -4.34%
vs SPY 1M: -14.75%

Industry peers

FMP comparable companies · ranked by market cap

KODBUYKodiak Sciences Inc.$5.9BBULLQ 42$94.26+5.95%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news